期刊文献+

肺癌细胞中NKG2D配体MICA及ULBP高表达及其在CIK介导的肿瘤细胞杀伤中的作用 被引量:8

High expression level of NKG2D ligands MICA and ULBP in lung cancer cell and the role in CIK mediated cytotoxicity
下载PDF
导出
摘要 目的:探索肺癌细胞中NKG2D配体的表达量及其与CIK细胞介导的肿瘤细胞毒性的关系。方法:在肺癌组织、癌旁组织及肺癌细胞株中用实时荧光定量PCR及蛋白质免疫印迹法检测NKG2D配体的表达量。应用流式细胞仪检测肿瘤细胞株A549和QG56表面NKG2D配体的表达情况。体外分离培养CIK细胞,比较NKG2D单克隆抗体预处理CIK细胞和无NKG2D单克隆抗体预处理CIK细胞介导的肿瘤细胞毒性。结果:NKG2D在肺癌组织及肺癌细胞株中高表达。CIK细胞对肺癌细胞株A549表现出较强的细胞毒性,但用NKG2D单克隆抗体预处理CIK细胞后可显著降低这种作用(P<0.05)。结论:NKG2D配体在肺癌组织和肺癌细胞株中高表达。对于CIK细胞介导的肺癌细胞杀伤作用,NKG2D与其配体的相互作用至关重要。 Objective: To identify the expression level of NKG2 D ligands in lung cancer cell and the interaction between NKG2 D and NKG2 D ligands in the CIK mediated cytotoxicity against tumor cells. Methods: We used RTPCR and Western-blot to detect the expression level of NKG2 D ligands in lung cancer tissue,para-carcinoma tissues and cell lines. The expression of NKG2 D ligands in the surface of lung cancer cell lines was determined by flowcytometry. CIK cells were isolated and cultured in vitro. The anti-NKG2 D mA bs treated CIK and non-anti-NKG2 D mA bs treated CIK cells mediating cytotoxicity against A549 was determined by flow cytometry also. Results:NKG2D ligands highly expressed in lung cancer cells. The CIK cells caused cytolysis against the A549,but this cytolysis was decreased( 30% ± 3. 2%) by pretreatment of CIK cells with anti-NKG2 D mA bs. Conclusion: The present study demonstrates the higher expression level of NKG2 D ligands in lung cancer tissue than para-carcinoma tissue. The killing effect of lung cancer cells by CIK cell is partially mediated by NKG2D-NKG2 D ligand interaction. The interaction between NKG2 D and NKG2 D ligands play a vital role in the CIK mediated tumor cell killing.
出处 《东南大学学报(医学版)》 CAS 北大核心 2016年第6期861-865,共5页 Journal of Southeast University(Medical Science Edition)
基金 南京医科大学重点医学项目(2012NJMU126)
关键词 肺癌 NKG2D配体 CIK细胞 MICA/B lung cancer NKG2D ligands CIK cells MICA/B
  • 相关文献

参考文献3

二级参考文献11

  • 1梅家转,郭坤元,魏红,梅常红.不同肿瘤细胞表面MICA的表达及NK细胞杀伤活性的研究[J].中国免疫学杂志,2007,23(1):34-37. 被引量:16
  • 2UMAR A,DUNN B K, GREENWALD P. Future directions in cancer prevention [ J ]. Nat Rev Cancer, 2012, 12 ( 12 ) : 835-848.
  • 3SANCHEZ-CORREA B,MORGADO S, GAYOSO I, et al. Hu- man NK cells in acute myeloid leukaemia patients:analysis of NK cell-activating receptors and their ligands [ J ]. Cancer Im- munol Immunother,2011,60(8 ) : 1195-1205.
  • 4STERN-GINOSSAR N, GUR C, BITON M, et al. Human mi- croRNAs regulate stress-induced immune responses mediated by the receptor NKG2D [ J ]. Nat Immunol, 2008, 9 ( 9 ) : 1065-1073.
  • 5KRIZHANOVSKY V, YON M, DICKINS R A, et al. Senes- cence of activated stellate cells limits liver fibrosis [ J ]. Cell, 2008,134(4) :657-667.
  • 6NANA-SINKAM S P, CROCE C M. Clinical applications for microRNAs in cancer[ J ]. Clin Pharmacol Ther,2013,93 (1) : 98-104.
  • 7NAGY Z, SZABO D R, ZSIPPAI A, et al. Relevance of long non-coding RNAs in tumour biology [ J ]. Orv Hetil,2012,153 (38) :1494-1501.
  • 8HAYAKAWA Y. Targeting NKG2D in tumor surveillance Jl. Expert Opin Ther Targets,2012,16(6) :587-599.
  • 9高佩芳,姚茹冰,蔡辉.树突状细胞在类风湿关节炎免疫耐受治疗中的作用[J].现代医学,2009,37(4):316-318. 被引量:5
  • 10林琳,沈洪,王立新,周晓波,吴静,徐艺,赵崧,刘增巍,葛超,刘亚军.黄芪甲苷、β-榄香烯对小鼠树突状细胞免疫功能的影响[J].东南大学学报(医学版),2011,30(2):294-297. 被引量:39

共引文献23

同被引文献65

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部